US medical device company Adagio Medical raises $42.5m in Series E
Adagio Medical, a California-based medical device company focused on developing treatment of atrial fibrillation (AF) and ventricular tachycardia (VT), has raised $42.5 million in a Series E equity financing round. The company has also developed the intelligent Continuous Lesion Ablation System (iCLAS). Its Series E financing round included new investors ArrowMark Partners, Perceptive Advisors, and […]
CATALYST clinical trial : FDA approves Abbott’s trial of Amplatzer Amulet device in AF
February 4, 2020 No Comment
Abbott has been granted approval from the US Food and Drug Administration (FDA) for the CATALYST clinical trial to assess its Amplatzer Amulet Left Atrial Appendage Occluder for people with atrial fibrillation (AF). According to the US medical device company, the CATALYST trial is the first-ever clinical trial that will compare the effectiveness of a […]
Continue reading …
Micro Labs and Mylan Pharmaceuticals have secured approval from the US Food and Drug Administration (FDA) for two applications for the first generics of Eliquis (apixaban) tablets to cut down the risk of stroke and systemic embolism in patients having nonvalvular atrial fibrillation. Apixaban is also indicated for the preventive treatment of deep vein thrombosis […]
Continue reading …
Correvio Pharma said that the US Food and Drug Administration (FDA) decided not to approve its anti-arrhythmic drug Brinavess (vernakalant IV). In this connection, the Canadian specialty pharma company has been issued a complete response letter (CRL) from the FDA stating that it cannot approve the new drug application (NDA) for Brinavess in its present […]
Continue reading …Mobile health devices could detect common heart condition atrial fibrillation, says study
September 4, 2019 No Comment
Mobile health (mHealth) devices could help screen and detect a common heart condition atrial fibrillation (AF), according to the new study. Atrial fibrillation is a heart rhythm disturbance, affecting around one million people in the UK. People with atrial fibrillation are at increased risk of having a stroke and dying, as well as heart failure […]
Continue reading …
AtriCure acquisition of SentreHEART : Afib device manufacturer AtriCure has agreed to acquire California-based medical device company SentreHEART in a deal worth up to about $300 million. Based in Ohio, AtriCure makes devices for the treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management. AtriCure’s Isolator Synergy Ablation System is the first and […]
Continue reading …Boston Scientific’s LUMINIZE RF Balloon Catheter meets objective in AF-FICIENT I trial
March 23, 2019 No Comment
Boston Scientific said that its LUMINIZE Radiofrequency (RF) Balloon Catheter (LUMINIZE RF Balloon Catheter), which is intended to be used for isolating pulmonary veins during treatment of patients with atrial fibrillation (AF), has achieved positive safety and efficacy results in the AF-FICIENT I clinical trial. Atrial fibrillation patients are usually treated with anti-arrhythmic drugs and […]
Continue reading …
Business News Today
- PostBank Uganda launches new debit card – UnionPay PostCard
- Lightnet Group strikes partnership with Thailand’s Siam Commercial Bank
- JinkoSolar to divest stake in 1.2GW Sweihan Power Station in Abu Dhabi
- CBAK Energy to supply battery packs to EV manufacturer Kandi Vehicles
- Flanagan Associates acquired by World Insurance Associates
- Chinese lifestyle product retailer MINISO opens new store in Madrid
- Unilever to acquire Los Angeles-based SmartyPants Vitamins
- Bega Cheese to acquire Lion Dairy & Drinks for $412m
- Nestlé to sell Yinlu peanut milk and canned rice porridge businesses in China
- TEXRail extension project : Trinity Metro selects AECOM as project consultant
